# LIGAND PHARMACEUTICALS INC LIGAND PHARMA (TR BETA) CVR

LIGAND PHARMACEUTICALS INC LIGAND PHARMA (TR BETA) CVR is a security (CUSIP 53220K173) tracked across SEC portfolio filings. 1 registered fund positions totaling $92 via N-PORT as of 2026-05-31.

## Summary

- Issuer: LIGAND PHARMACEUTICALS INC
- Class: LIGAND PHARMA (TR BETA) CVR
- CUSIP: 53220K173
- Asset category: EC
- 13F holders: 0
- N-PORT fund positions: 1
- N-PORT value: $92
- N-PORT report: 2026-05-31

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Fidelity Nasdaq Composite Index ETF](https://search.stillhousedata.com/fund/S000006011) | Fidelity Commonwealth Trust | $92 | 0.00% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/53220K173.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.